Barbara L. Rellahan

Statistics

Publications

Citations

1.6K

H-Index

Active since

1987

Affiliations

Center for Biologics Evaluation and Research(Current)

National Institutes of Health

National Cancer Institute

Center for Drug Evaluation and Research

United States Food and Drug Administration

Barbara L. Rellahan is an author at Center for Biologics Evaluation and Research specializing in life sciences, molecular biology, and signal transduction.

Publications per year

1987–2020

Publications

In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.

Barbara L. Rellahan, Lisa Jones, A M Kruisbeek et al. · The Journal of Experimental Medicine · 1990 · 359 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Activation-Induced Ubiquitination of the T Cell Antigen Receptor

Cristina Cenciarelli, Kou‐Ching Hsu, Barbara L. Rellahan et al. · Science · 1992 · 212 citations

Life Sciences, Immunology, Molecular Biology +15

Phospholipase C–mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane

Jian-Jiang Hao, Yin Liu, Michael J. Kruhlak et al. · The Journal of Cell Biology · 2009 · 141 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer

Gideon M. Blumenthal, Nancy S. Scher, Patricia Cortazar et al. · Clinical Cancer Research · 2013 · 120 citations

Medicine, Oncology, Pharmacology +16

Phosphorylation and <i>O</i> -Linked Glycosylation of Elf-1 Leads to Its Translocation to the Nucleus and Binding to the Promoter of the TCR ζ-Chain

Yuang‐Taung Juang, Elena E. Solomou, Barbara L. Rellahan et al. · The Journal of Immunology · 2002 · 77 citations

Life Sciences, Biochemistry, Molecular Biology +13

1–5 of 23